Get startedLog in
    Picture of Evelo Biosciences logo

    EVLO — Evelo Biosciences News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: Evelo Biosciences Inc Says As Of December 31, 2021, Cash And Cash Equivalents Were $68.4 Million

    Picture of Evelo Biosciences logoEvelo Biosciences
    24/03/2022 10:20
    March 24 (Reuters) - Evelo Biosciences Inc  EVLO.O :
    * AS OF DECEMBER 31, 2021, CASH AND CASH EQUIVALENTS WERE
$68.4
MILLION
    * QTRLY LOSS PER SHARE $0.54
    * Q4 EARNINGS PER SHARE VIEW $-0.61 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX3pVM9L 
Further company coverage:  EVLO.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Evelo Biosciences

    See all news